Zevotrelvir
Modify Date: 2025-08-25 22:33:37
Zevotrelvir structure
|
Common Name | Zevotrelvir | ||
|---|---|---|---|---|
| CAS Number | 2773516-53-1 | Molecular Weight | 537.53 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H26F3N5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ZevotrelvirZevotrelvir (Compound 52) is a coronavirus inhibitor with IC50 ranges of <0.1 μM and <0.1mM for 229E hCoV and SARS-CoV-23C-like (3CL) proteases, respectively. Zevotrelvir has the potential to study viral infections[1]. |
| Name | Zevotrelvir |
|---|
| Description | Zevotrelvir (Compound 52) is a coronavirus inhibitor with IC50 ranges of <0.1 μM and <0.1mM for 229E hCoV and SARS-CoV-23C-like (3CL) proteases, respectively. Zevotrelvir has the potential to study viral infections[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Guoqiang Wang, et al. Novel spiropyrrolidine derived antiviral drugs. Patent CN114524821A. |
| Molecular Formula | C28H26F3N5O3 |
|---|---|
| Molecular Weight | 537.53 |
| InChIKey | ZVSKSJFRHVXDPS-JNFGOLMQSA-N |
| SMILES | CC(C)CC(C(=O)N1CC2(CC1C#N)C(=O)Nc1ccccc12)N(C)C(=O)c1cc2c(F)cc(F)c(F)c2[nH]1 |